Routine aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
Myocardial infarction
percutaneous coronary intervention
stroke
thrombectomy
Journal
American journal of cardiovascular disease
ISSN: 2160-200X
Titre abrégé: Am J Cardiovasc Dis
Pays: United States
ID NLM: 101569582
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
06
2020
accepted:
16
11
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
26
1
2021
Statut:
epublish
Résumé
Recent studies have suggested that the routine use of aspiration thrombectomy catheters during primary percutaneous coronary intervention (PCI) do not result in improved mortality and may be associated with an increased stroke rate. This study sought to investigate this hypothesis. This was an observational study analysing data from a prospective database of 6366 patients undergoing primary PCI between August 2003 and May 2015 at a UK cardiac centre. Patients' details were collected from the hospital electronic database. Primary outcome was thirty-day stroke rates. 3989 (62.7%) patients underwent PCI alone and 2,377 (37.3%) patients underwent PCI with adjuctive thrombus aspiration. PCI alone group had an older demographic (63 (± 14) years vs 60.7 (± 14)), a lower proportion of male participants 75% vs 79% (P=0.001) and cardiovascular risk factors such as hypertension 22.4% vs 25.3% (P=0.007), hypercholesterolemia 18.5% vs 22.6% (P<0.0001) and a history of smoking 33.5% vs 44.3% (P<0.0001). Thrombus aspiration was associated with a higher 30-day stroke rate [16 (0.7%) vs 11 (0.3%) (HR 2.51; 95% CI 1.03-6.08, P 0.03). Multivariate analysis suggested that this increased risk of stroke was maintained following adjustment for confounders (HR: 1.86; 95% CI 1.02-4.38). There was 379 deaths of which 114 (4.8%) were in the thrombus aspiration cohort vs 265 (6.6%) in PCI only cohort over the follow-up period (60 months). This resulted in a significantly lower rate of all-cause-mortality HR 0.70 (95% CI 0.52-0.94; P 0.02). There was no statistically significant difference in observed myocardial infarction rates HR 0.76 (95% CI 0.47-1.23; P 0.27) and the rates of unscheduled revascularisations HR 0.70 (95% CI 0.43-1.13; P 0.14) between the two groups. Our data series of STEMI patients, suggest that routine thrombus aspiration during primary PCI is associated with a significantly higher stroke, rate however, thrombus aspiration reduced mortality rate. This is consistent with current guidelines which don't recommend the routine use of thrombus aspiration for primary PCI. A possible mortality reduction in patients with high thrombus grades was seen which may warrant further study.
Sections du résumé
BACKGROUND
BACKGROUND
Recent studies have suggested that the routine use of aspiration thrombectomy catheters during primary percutaneous coronary intervention (PCI) do not result in improved mortality and may be associated with an increased stroke rate. This study sought to investigate this hypothesis.
METHODS
METHODS
This was an observational study analysing data from a prospective database of 6366 patients undergoing primary PCI between August 2003 and May 2015 at a UK cardiac centre. Patients' details were collected from the hospital electronic database. Primary outcome was thirty-day stroke rates.
RESULTS
RESULTS
3989 (62.7%) patients underwent PCI alone and 2,377 (37.3%) patients underwent PCI with adjuctive thrombus aspiration. PCI alone group had an older demographic (63 (± 14) years vs 60.7 (± 14)), a lower proportion of male participants 75% vs 79% (P=0.001) and cardiovascular risk factors such as hypertension 22.4% vs 25.3% (P=0.007), hypercholesterolemia 18.5% vs 22.6% (P<0.0001) and a history of smoking 33.5% vs 44.3% (P<0.0001). Thrombus aspiration was associated with a higher 30-day stroke rate [16 (0.7%) vs 11 (0.3%) (HR 2.51; 95% CI 1.03-6.08, P 0.03). Multivariate analysis suggested that this increased risk of stroke was maintained following adjustment for confounders (HR: 1.86; 95% CI 1.02-4.38). There was 379 deaths of which 114 (4.8%) were in the thrombus aspiration cohort vs 265 (6.6%) in PCI only cohort over the follow-up period (60 months). This resulted in a significantly lower rate of all-cause-mortality HR 0.70 (95% CI 0.52-0.94; P 0.02). There was no statistically significant difference in observed myocardial infarction rates HR 0.76 (95% CI 0.47-1.23; P 0.27) and the rates of unscheduled revascularisations HR 0.70 (95% CI 0.43-1.13; P 0.14) between the two groups.
CONCLUSIONS
CONCLUSIONS
Our data series of STEMI patients, suggest that routine thrombus aspiration during primary PCI is associated with a significantly higher stroke, rate however, thrombus aspiration reduced mortality rate. This is consistent with current guidelines which don't recommend the routine use of thrombus aspiration for primary PCI. A possible mortality reduction in patients with high thrombus grades was seen which may warrant further study.
Types de publication
Journal Article
Langues
eng
Pagination
548-556Subventions
Organisme : Department of Health
ID : DRF-2014-07-008
Pays : United Kingdom
Informations de copyright
AJCD Copyright © 2020.
Déclaration de conflit d'intérêts
None.
Références
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Korean Circ J. 2020 Nov;50(11):1026-1036
pubmed: 33118336
JAMA. 2012 May 2;307(17):1817-26
pubmed: 22447888
Int J Cardiol. 2020 Nov 15;319:40-45
pubmed: 32470531
BMJ Open. 2013 Jun 28;3(6):
pubmed: 23811175
BMC Cardiovasc Disord. 2018 Apr 24;18(1):69
pubmed: 29699478
JACC Cardiovasc Interv. 2012 Dec;5(12):1223-30
pubmed: 23257370
JACC Cardiovasc Interv. 2016 Jan 25;9(2):113-22
pubmed: 26793952
Circulation. 2017 Jan 10;135(2):143-152
pubmed: 27941066
N Engl J Med. 2013 Oct 24;369(17):1587-97
pubmed: 23991656
Am Heart J. 2015 Dec;170(6):1116-23
pubmed: 26678633
N Engl J Med. 2015 Apr 9;372(15):1389-98
pubmed: 25853743
Am Heart J. 2010 Dec;160(6):1042-8
pubmed: 21146656
Eur Heart J. 2009 Sep;30(18):2193-203
pubmed: 19726437
Eur Heart J. 2008 Dec;29(24):3002-10
pubmed: 18775918
Clin Res Cardiol. 2019 Nov;108(11):1208-1214
pubmed: 30859380
J Am Coll Cardiol. 2016 Mar 15;67(10):1235-1250
pubmed: 26498666
Am Heart J. 2016 Feb;172:129-34
pubmed: 26856224
JAMA Cardiol. 2019 Feb 1;4(2):110-118
pubmed: 30624549
Lancet. 2008 Jun 7;371(9628):1915-20
pubmed: 18539223
Circ Cardiovasc Interv. 2013 Apr;6(2):176-83
pubmed: 23549644